找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Management of Hypertension; Current Practice and Vasilios Papademetriou,Emmanuel A. Andreadis,Chara Book 2019 Springer International Publis

[復制鏈接]
樓主: odometer
11#
發(fā)表于 2025-3-23 11:05:35 | 只看該作者
12#
發(fā)表于 2025-3-23 15:35:44 | 只看該作者
Arterial Hypertension and Cardiovascular Riskotal cardiovascular risk (i.e., the likelihood of developing a cardiovascular event, usually within the next 10 years), most of which are based either on the Framingham risk score or the European SCORE (Systemic Coronary Risk Evaluation) project. The 2013 ESH-ESC guidelines suggest subclinical organ
13#
發(fā)表于 2025-3-23 19:36:05 | 只看該作者
The VA Co-operative Studies; The First RCTs in Cardiovascular Disease – A Tribute to Edward D. Freis], and the association continued to be strengthened by data from the same source accumulated over the next 3 decades. The beneficial effects of blood pressure reduction however, remained controversial till the mid 1950s because of the luck of effective therapies and the fear of harming vital organs
14#
發(fā)表于 2025-3-23 22:17:21 | 只看該作者
15#
發(fā)表于 2025-3-24 03:23:26 | 只看該作者
16#
發(fā)表于 2025-3-24 07:47:14 | 只看該作者
Management of Hypertension in Diabetes Mellitusase) and microvascular (nephropathy, retinopathy) complications. Diabetes mellitus is associated with a two-fold to three-fold increased risk for cardiovascular events and is the leading cause of chronic kidney disease with almost half of end-stage renal disease cases being attributed to diabetes [1
17#
發(fā)表于 2025-3-24 11:35:04 | 只看該作者
Chronic Kidney Disease and Hypertensionnetically susceptible individuals. The second most common cause of end-stage renal disease continues to be hypertension. Increased blood pressure participates in the pathogenesis of renal disease and the kidney is crucial in the long-term regulation of blood pressure. The development of hypertension
18#
發(fā)表于 2025-3-24 17:36:57 | 只看該作者
19#
發(fā)表于 2025-3-24 20:18:02 | 只看該作者
Comparison Therapies in the Treatment of Hypertension. The ASCOT and ACCOMPLISH Trialng interest, as in the majority of patients monotherapy does not achieve blood pressure control. Combination therapy seems safe, effective and convenient and several regimens are available in single-pill form, thereby facilitating compliance. Selection of the proper regimen remains a matter of debat
20#
發(fā)表于 2025-3-25 02:15:02 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 01:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
揭西县| 平遥县| 滨海县| 晋城| 黄浦区| 沾益县| 遂昌县| 滦南县| 天长市| 陇南市| 苏尼特右旗| 吉安市| 陇西县| 永定县| 绥滨县| 新田县| 扎鲁特旗| 丹寨县| 永安市| 蕉岭县| 温宿县| 绥芬河市| 巴南区| 个旧市| 赤峰市| 浦江县| 汝城县| 仪陇县| 镇原县| 永昌县| 盐山县| 溧水县| 自治县| 凤翔县| 壶关县| 司法| 阜新市| 龙井市| 宣汉县| 贵港市| 双流县|